ミュシャとその周辺 (アール・ヌーヴォーとアルフォンス・ミュシャ(特集))

G-CSF administration in acute MI patients was feasible and did not lead to any clinical or angiographic adverse events and resulted in CD34(+) and CD34(+)AC133(+)VEGFR2(+) cell mobilization.